What Safilens does

Safilens S.r.l. Unipersonale is an Italian medical device company founded in 2001 and headquartered in Staranzano (Gorizia), Italy. The company designs, manufactures, and commercializes a full portfolio of soft contact lenses (Fusion 1day, Fusion 7days, Open 30, Safe-Gel, Delivery), complementary lens care solutions (Fusionsol, Open Reload, Safe-Gel Hyal), lubricating eye drops, and the Sonic Wave Generator sonication device. Its technology platform centers on three proprietary systems: Fusiontechnology combining Hyaluronic Acid (HA) and Tamarind Seed Polysaccharide (TSP) for controlled release onto the tear film, the Lachryceuticals platform for embedding natural substances (amino acids, vitamins, riboflavin) within the lens matrix, and the Afocal EDOF/D-Stress optical designs for presbyopia and digital eye strain correction. Safilens operates under ISO 13485:2016 and EU Medical Device Regulation certifications.

The company has been a wholly-owned subsidiary of Bruno Farmaceutici (an Italian pharmaceutical company founded in Rome in 1996) since 2012, which provides pharmaceutical R&D capabilities. Safilens sells exclusively through the optical retail channel: in Italy via its own sales force, and internationally through a network of exclusive country-level distributors covering 14+ markets including Germany, Austria, Switzerland, Denmark, Netherlands, Spain, UK, Ireland, Bulgaria, North Macedonia, Bahrain, Israel, and Turkey. Pricing is not publicly disclosed and online sales are contractually restricted for certain prescription products. End customers are eye care professionals (opticians, optometrists) who prescribe and fit Safilens lenses to patients requiring myopia, hyperopia, astigmatism, and presbyopia correction, with growing emphasis on digital eye strain management and myopia control.

Name

Safilens

Legal name

Safilens S.r.l. Unipersonale

Website

https://safilens.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

51–100 employees

Short description

Safilens is an Italian medical device company that designs and manufactures proprietary soft contact lenses, lens care solutions, and eye drops using controlled-release technology (HA, TSP, Lachryceuticals), selling exclusively through optical retail channels via its own sales force in Italy and a network of exclusive international distributors across 14+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Staranzano

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Contact Lenses (Daily, Weekly, Monthly): Sale of proprietary hydrogel and silicone-hydrogel contact lenses in multiple modalities (daily disposable, weekly replacement, monthly replacement) across multiple segments (myopia/hyperopia, presbyopia, astigmatism). Products include Fusion 1day, Fusion 7days, Open 30, Delivery, Safe-Gel lines.
2. Lens Care Solutions: Multipurpose solutions for cleaning, disinfecting, and maintaining reusable soft contact lenses. Includes Fusionsol, Open Reload, and Safe-Gel Hyal products with hyaluronic acid and TSP formulations.
3. Eye Drops / Lubricants: Eye drops for ocular surface lubrication and therapeutic use, including DROP therapeutic and Safe-Gel Hyal Comfort Drops sold through the optical channel.
4. DROP therapeutic Distribution: Safilens acts as exclusive distributor in the optical channel for DROP therapeutic eye drops, a formulation developed by Servimed in collaboration with Bruno Farmaceutici.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Safilens designs, manufactures and commercializes medical devices consisting of a full range of contact lenses (daily, weekly and monthly disposable), multipurpose lens care solutions, and lubricating/therapeutic eye drops. Its products embed patented controlled-release technologies (Fusiontechnology combining Hyaluronic Acid and Tamarind Seed Polysaccharide, and the Lachryceuticals system) that release natural substances onto the tear film during wear to improve comfort and ocular surface health. The portfolio addresses refractive correction (myopia, hyperopia, astigmatism, presbyopia), digital eye strain, myopia control, and ocular surface therapy.

Product overview

Safilens offers a comprehensive portfolio of contact lenses and complementary products centered around three proprietary technology platforms: fusiontechnology (Hyaluronic Acid + TSP® controlled release), the EDOF Afocal/D-stress design for presbyopia and digital eye strain, and the Delivery/Lachryceuticals® system for controlled release of therapeutic substances. The core product lines include Fusion 1day (daily disposable spherical/astigmatic/presbyopic/vista), Fusion 7days (weekly replacement spherical/astigmatic/presbyopic), Open 30 (monthly silicone-hydrogel spherical/presbyopic), Safe-Gel (daily/weekly/monthly lenses with hyaluronic acid embedded in the matrix), and Delivery (daily lenses releasing Tyrosine or Riboflavin). These are supported by a range of multipurpose lens care solutions (Fusionsol, Open Reload, Safe-Gel Hyal), lubricating eye drops (DROP therapeutic, Safe-Gel Hyal Comfort Drops), and the Sonic Wave Generator device for overnight lens regeneration.

Differentiator

Problem solved

Functional benefit

Brands

• Fusion 1day: Daily disposable enriched hydrogel contact lens that releases natural polymers (Hyaluronic Acid and TSP). Available in 4 segments including astigma, presbyo, and vista variants.
• Fusion 7days
• Open 30
• Delivery
• Safe-Gel

Products and services

• Fusion 1day Daily disposable hydrogel contact lens enriched with Hyaluronic Acid and TSP via fusiontechnology, providing longer high-quality wearing performance. Available in four segments: spherical, astigmatic (SleekForm design), presbyopic (Afocal EDOF design) and Vista (D-stress EDOF design for digital device users). Sold exclusively through optical retailers.
• Fusion 7days Weekly replacement hydrogel contact lens with controlled release of Hyaluronic Acid and TSP. Available in spherical, astigmatic (SleekForm toric) and presbyopic (Afocal EDOF) variants. Can be regenerated overnight using the Sonic Wave Generator and fusionsol solution.
• Open 30 Monthly replacement silicone-hydrogel contact lens featuring fusiontechnology with Hyaluronic Acid and TSP release. Available in spherical and Presbyo (Afocal EDOF design) variants, with optimal DK for daily wear, ultra-smooth surface and low modulus.
• Delivery (Tyro and Ribo) Daily disposable contact lenses that release Lachryceuticals (natural substances including amino acids and vitamins) onto the tear film during wear. Delivery Tyro releases Tyrosine for ocular development; Delivery Ribo releases Riboflavin and Vitamin E-TPGS for protection from digital eye strain, blue light, UV and HEV radiation.
• Safe-Gel Hydrogel contact lenses incorporating hyaluronic acid directly within the lens matrix as a tear substitute. Available in daily disposable (Safe-Gel 1day), weekly (Safe-Gel 7days) and monthly (Safe-Gel FRP) replacement options. Safe-Gel 1day is described as the world's first contact lens to incorporate hyaluronic acid within the matrix.
• Lens Care Solutions Multipurpose solutions for cleaning, disinfecting and hydrating soft contact lenses. Includes Fusionsol (with HA and TSP), Open Reload (with HA and TSP) and Safe-Gel Hyal (with hyaluronic acid). Compatible with the Sonic Wave Generator sonication device for overnight lens regeneration.
• Eye Drops (Umettanti) Lubricating and therapeutic eye drops providing relief from dryness, redness, irritation, fatigue and itching. DROP therapeutic contains Riboflavin, Vitamin E-TPGS, Hyaluronic Acid and Amino Acids; Safe-Gel Hyal Comfort Drops contain 0.2% hyaluronic acid.
• Sonic Wave Generator (SWG) Patented sonic wave device used with Fusion 7days and compatible lens care solutions to enable overnight absorption of substances inside the lens matrix for subsequent release, and removal of protein deposits, using an expanded sinusoidal frequency range.

Quantifiable outcome

• Safe-Gel is described as the world's first contact lenses incorporating hyaluronic acid within the matrix.
• +1 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Eleven partnerships are on record, tiered core, flagship and minor.

• Lindcon Linser A/S (Denmark)coreChannel Partner/ Reseller/ Distributor · 1 July 2021Three-year distribution partnership (2021) for the distribution of the full Safilens portfolio, particularly Fusion daily lenses and the Delivery family, through the extensive optical and optometry network in Denmark. Lindcon Linser A/S is based in Skødstrup, Denmark, with over 50 years of experience supplying contact lenses, diagnostic equipment, instruments, and spare parts to opticians and ophthalmic clinics.
• MPG&E Handel und Service GmbH (Germany)coreChannel Partner/ Reseller/ Distributor · 1 July 2017Five-year exclusive distribution partnership (2017) for Germany. MPG&E is based in Bordesholm, northern Germany, specializing in contact lenses and care products for opticians and optometrists with a reputation for anticipating international market trends and providing innovative products with impeccable service.
• Bruno FarmaceuticiflagshipStrategic or Co-development Partner · 1 January 2012Safilens has been part of Bruno Farmaceutici since 2012. Bruno Farmaceutici is an Italian pharmaceutical company founded in Rome in 1996, leader in Italy in oral cortisone and anti-diabetic sectors. The acquisition made available to Safilens the wealth of scientific skills and pharmaceutical know-how of the group. Safilens continues to operate as a modern and independent entity developing products focused on user well-being.
• Veneto Eye Bank Foundation (Fondazione Banca degli Occhi del Veneto ONLUS)coreStrategic or Co-development PartnerCollaboration with the Eye Bank Foundation — a leading European institute in eye research, transplantation, and ocular disease care for over 30 years — in the development of new contact lens technologies. The partnership contributed to the development of the Delivery family of lenses launched in 2021.
• University of SalentominorStrategic or Co-development PartnerLong-term research collaboration with the Department of Sciences for a Bachelor's Degree in Optics and Optometry. Activities include screening of population groups and the study of new materials, new geometries, and advanced instrumentation for optometric applications.
• Servimed / Bruno Farmaceutici (for DROP therapeutic)coreChannel Partner/ Reseller/ DistributorSafilens acts as exclusive distributor in the optical channel for DROP therapeutic eye drops, a unique patented formulation developed by Servimed in collaboration with Bruno Farmaceutici. DROP therapeutic contains Riboflavin (B2), Vitamin E-TPGS, Amino Acids, and Hyaluronic Acid for corneal epithelium protection.
• ANYWAVE (Sailing Team)minorOthersMain sponsor since 2017 of the ANYWAVE racing sailboat. The sponsorship promotes environmental protection of the sea and awareness of individual responsibility for environmental preservation.
• Safilens UK Ltd. (UK & Ireland)coreChannel Partner/ Reseller/ DistributorRegional subsidiary/distributor managing Safilens product sales in the UK and Ireland. Contact: [email protected], managed by Country Manager Ian McDermott.
• Ottiko GmbH (Austria)coreChannel Partner/ Reseller/ DistributorExclusive distributor for Austria with 8-year partnership, supplying innovative Safilens contact lens products to Austrian opticians.
• Conil AG (Switzerland)coreChannel Partner/ Reseller/ DistributorLong-term distribution partner in Switzerland offering Safilens innovative products as added value in the optical retail portfolio.
• Visionis Distribucion S.L. (Spain)coreChannel Partner/ Reseller/ DistributorExclusive distributor for Spain managing Safilens product sales through the Spanish optical retail channel.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Emerging players

• Paragon Vision Sciences: Specialty contact lens company focused on corneal reshaping and gas-permeable designs including myopia-control ortho-k. Comparable to Safilens as a smaller specialty contact lens player pursuing controlled-delivery and myopia-control strategies in the professional channel.
• mark'ennovy Personalized Care: European custom and specialty contact lens manufacturer focused on toric, multifocal, and myopia-control lenses. Comparable to Safilens as a smaller, innovation-led specialty lens manufacturer competing in the same optician channel with custom parameters and EDOF-style designs.

Direct peers

• Menicon: Japanese specialty contact lens manufacturer with strong presence in RGP, ortho-k, and specialty soft lenses. Comparable as a specialty contact lens company developing differentiated designs and materials (e.g., for presbyopia and myopia) for the eye-care professional channel.
• CooperVision: One of the world's largest contact lens manufacturers with a broad daily, weekly, and monthly portfolio. Directly comparable as a contact lens specialist competing for the same optician channel and patient set, though at substantially greater scale.

Broad incumbents

• Essilor (EssilorLuxottica): Global leader in ophthalmic lenses and eyewear retail with growing ophthalmic device exposure. Comparable as the dominant European optical goods manufacturer/retailer with deep optician relationships and premium branding that frames Safilens' go-to-market context.
• Alcon: Major ophthalmic medical device company with a leading contact lens and lens-care franchise (Dailies, Air Optix, Opti-Free). Broadly comparable as a large diversified ophthalmic player offering overlapping daily, toric, and presbyopia products through the same optical retail channel.
• Bausch + Lomb: Long-established ophthalmic device and lens care company spanning contact lenses (Biotrue, Ultra) and lens care solutions (Renu). Comparable as a full-portfolio contact lens manufacturer and lens care player serving the same optician channel as Safilens.
• HOYA Vision Care: Major ophthalmic lens player producing spectacle lenses and a specialty contact lens portfolio (MiYOSMART for myopia management). Comparable as an optician-channel supplier with a myopia-control franchise and broader ophthalmic technology base.
• Johnson & Johnson Vision (Acuvue): Operates the Acuvue family of contact lenses and dominates the global mass-market contact lens category. Comparable as the incumbent against whose differentiated daily and toric/presbyo offerings Safilens competes for shelf space and optician recommendation.
• Carl Zeiss Meditec: Broad medical technology company active across ophthalmic diagnostics, surgical, and vision-care products. Comparable as an established ophthalmic technology incumbent with premium positioning and EU regulatory depth that Safilens competes against for higher-end optician recommendation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/safilens
• Facebookfacebook.com/Safilens
• LinkedInlinkedin.com/company/safilens
• Instagraminstagram.com/safilens_2020

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Safilens